{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:22:46Z","timestamp":1777710166599,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05565-w","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T18:01:57Z","timestamp":1710957717000},"page":"1179-1184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The interplay between rheumatic diseases and pulmonary health"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5042-1191","authenticated-orcid":false,"given":"Yuliya","family":"Fedorchenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1262-5609","authenticated-orcid":false,"given":"Roman","family":"Yatsyshyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-8928","authenticated-orcid":false,"given":"Bohdana","family":"Doskaliuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3265-1273","authenticated-orcid":false,"given":"Liubomyr","family":"Zaiats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-791X","authenticated-orcid":false,"given":"Mykhailo","family":"Fedorchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"issue":"4","key":"5565_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 20(4):102776. https:\/\/doi.org\/10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun Rev"},{"issue":"2","key":"5565_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00296-020-04764-5","volume":"41","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 41(2):243\u2013256. https:\/\/doi.org\/10.1007\/s00296-020-04764-5","journal-title":"Rheumatol Int"},{"issue":"5","key":"5565_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2174\/1570161118666200129125320","volume":"18","author":"K Melissaropoulos","year":"2020","unstructured":"Melissaropoulos K, Bogdanos D, Dimitroulas T, Sakkas LI, Kitas GD, Daoussis D (2020) Primary Sj\u00f6gren\u2019s syndrome and cardiovascular disease. Curr Vasc Pharmacol 18(5):447\u2013454. https:\/\/doi.org\/10.2174\/1570161118666200129125320","journal-title":"Curr Vasc Pharmacol"},{"issue":"12","key":"5565_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00296-023-05453-9","volume":"43","author":"Y Fedorchenko","year":"2023","unstructured":"Fedorchenko Y, Mahmudov K, Abenov Z, Zimba O, Yessirkepov M (2023) Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations. Rheumatol Int 43(12):2167\u20132174. https:\/\/doi.org\/10.1007\/s00296-023-05453-9","journal-title":"Rheumatol Int"},{"issue":"1","key":"5565_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","volume":"11","author":"JJ Solomon","year":"2023","unstructured":"Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I et al (2023) Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Respir Med 11(1):87\u201396. https:\/\/doi.org\/10.1016\/S2213-2600(22)00260-0","journal-title":"Lancet Respir Med"},{"issue":"4","key":"5565_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.chest.2022.11.035","volume":"163","author":"SM Matson","year":"2023","unstructured":"Matson SM, Baqir M, Moua T, Marll M, Kent J, Iannazzo NS et al (2023) Treatment outcomes for rheumatoid arthritis-associated interstitial lung disease: a real-world, multisite study of the impact of immunosuppression on pulmonary function trajectory. Chest 163(4):861\u2013869. https:\/\/doi.org\/10.1016\/j.chest.2022.11.035","journal-title":"Chest"},{"issue":"3","key":"5565_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11655-015-2093-6","volume":"22","author":"L Wan","year":"2016","unstructured":"Wan L, Liu J, Huang CB, Wang Y, Chen X, Zhang WD et al (2016) Xinfeng capsule for the treatment of rheumatoid arthritis patients with decreased pulmonary function\u2013a randomized controlled clinical trial. Chin J Integr Med 22(3):168\u2013176. https:\/\/doi.org\/10.1007\/s11655-015-2093-6","journal-title":"Chin J Integr Med"},{"issue":"5","key":"5565_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/ar2767","volume":"11","author":"C Chizzolini","year":"2009","unstructured":"Chizzolini C, Dayer JM, Miossec P (2009) Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance? Arthritis Res Ther 11(5):246. https:\/\/doi.org\/10.1186\/ar2767","journal-title":"Arthritis Res Ther"},{"key":"5565_CR9","doi-asserted-by":"publisher","first-page":"2405291","DOI":"10.1155\/2017\/2405291","volume":"2017","author":"Y Tan","year":"2017","unstructured":"Tan Y, Qi Q, Lu C, Niu X, Bai Y, Jiang C et al (2017) Cytokine imbalance as a common mechanism in both psoriasis and rheumatoid arthritis. Mediators Inflamm 2017:2405291. https:\/\/doi.org\/10.1155\/2017\/2405291","journal-title":"Mediators Inflamm"},{"issue":"6","key":"5565_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178879","volume":"12","author":"S Mateen","year":"2017","unstructured":"Mateen S, Moin S, Shahzad S, Khan AQ (2017) Level of inflammatory cytokines in rheumatoid arthritis patients: correlation with 25-hydroxy vitamin D and reactive oxygen species. PLoS ONE 12(6):e0178879. https:\/\/doi.org\/10.1371\/journal.pone.0178879","journal-title":"PLoS ONE"},{"key":"5565_CR11","doi-asserted-by":"publisher","first-page":"153303382095180","DOI":"10.1177\/1533033820951807","volume":"19","author":"J Chen","year":"2020","unstructured":"Chen J, Li X, Huang C, Lin Y, Dai Q (2020) Change of serum inflammatory cytokines levels in patients with chronic obstructive pulmonary disease, pneumonia and lung cancer. Technol Cancer Res Treat 19:1533033820951807. https:\/\/doi.org\/10.1177\/1533033820951807","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"5565_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41420-021-00437-9","volume":"7","author":"YX She","year":"2021","unstructured":"She YX, Yu QY, Tang XX (2021) Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov 7(1):52. https:\/\/doi.org\/10.1038\/s41420-021-00437-9","journal-title":"Cell Death Discov"},{"issue":"7","key":"5565_CR13","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.3390\/ijms24076800","volume":"24","author":"N Mena-V\u00e1zquez","year":"2023","unstructured":"Mena-V\u00e1zquez N, Godoy-Navarrete FJ, Lisbona-Monta\u00f1ez JM, Redondo-Rodriguez R, Manrique-Arija S, Rioja J (2023) Inflammatory biomarkers in the diagnosis and prognosis of rheumatoid arthritis-associated interstitial lung disease. Int J Mol Sci 24(7):6800. https:\/\/doi.org\/10.3390\/ijms24076800","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5565_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41584-019-0275-x","volume":"15","author":"D Wang","year":"2019","unstructured":"Wang D, Zhang J, Lau J, Wang S, Taneja V, Matteson EL et al (2019) Mechanisms of lung disease development in rheumatoid arthritis. Nat Rev Rheumatol 15(10):581\u2013596. https:\/\/doi.org\/10.1038\/s41584-019-0275-x","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"5565_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102830","volume":"20","author":"EF Vicente-Rabaneda","year":"2021","unstructured":"Vicente-Rabaneda EF, Atienza-Mateo B, Blanco R, Cavagna L, Ancochea J, Casta\u00f1eda S et al (2021) Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: a systematic literature review. Autoimmun Rev 20(6):102830. https:\/\/doi.org\/10.1016\/j.autrev.2021.102830","journal-title":"Autoimmun Rev"},{"issue":"3","key":"5565_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12016-022-08926-0","volume":"63","author":"E De Zorzi","year":"2022","unstructured":"De Zorzi E, Spagnolo P, Cocconcelli E, Balestro E, Iaccarino L, Gatto M et al (2022) Thoracic involvement in systemic autoimmune rheumatic diseases: pathogenesis and management. Clin Rev Allergy Immunol 63(3):472\u2013489. https:\/\/doi.org\/10.1007\/s12016-022-08926-0","journal-title":"Clin Rev Allergy Immunol"},{"issue":"167","key":"5565_CR17","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0210-2022","volume":"32","author":"GM Joy","year":"2023","unstructured":"Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM et al (2023) Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev 32(167):220210. https:\/\/doi.org\/10.1183\/16000617.0210-2022","journal-title":"Eur Respir Rev"},{"issue":"8","key":"5565_CR18","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1007\/s10238-023-01202-1","volume":"23","author":"A Poerio","year":"2023","unstructured":"Poerio A, Carlicchi E, Zompatori M (2023) Diagnosis of interstitial lung disease (ILD) secondary to systemic sclerosis (SSc) and rheumatoid arthritis (RA) and identification of \u201cprogressive pulmonary fibrosis\u201d using chest CT: a narrative review. Clin Exp Med 23(8):4721\u20134728. https:\/\/doi.org\/10.1007\/s10238-023-01202-1","journal-title":"Clin Exp Med"},{"issue":"5","key":"5565_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/17476348.2022.2089116","volume":"16","author":"R Diesler","year":"2022","unstructured":"Diesler R, Cottin V (2022) Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies. Expert Rev Respir Med 16(5):541\u2013553. https:\/\/doi.org\/10.1080\/17476348.2022.2089116","journal-title":"Expert Rev Respir Med"},{"issue":"11","key":"5565_CR20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"issue":"5","key":"5565_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/MCP.0000000000000710","volume":"26","author":"PA Juge","year":"2020","unstructured":"Juge PA, Crestani B, Dieud\u00e9 P (2020) Recent advances in rheumatoid arthritis-associated interstitial lung disease. Curr Opin Pulm Med 26(5):477\u2013486. https:\/\/doi.org\/10.1097\/MCP.0000000000000710","journal-title":"Curr Opin Pulm Med"},{"issue":"6","key":"5565_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286191","volume":"18","author":"M Zhang","year":"2023","unstructured":"Zhang M, Yin J, Zhang X (2023) Factors associated with interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS ONE 18(6):e0286191. https:\/\/doi.org\/10.1371\/journal.pone.0286191","journal-title":"PLoS ONE"},{"issue":"1","key":"5565_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12931-021-01856-z","volume":"22","author":"M Qiu","year":"2021","unstructured":"Qiu M, Jiang J, Nian X, Wang Y, Yu P, Song J et al (2021) Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Respir Res 22(1):264. https:\/\/doi.org\/10.1186\/s12931-021-01856-z","journal-title":"Respir Res"},{"issue":"160","key":"5565_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0011-2021","volume":"30","author":"S Kadura","year":"2021","unstructured":"Kadura S, Raghu G (2021) Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management. Eur Respir Rev 30(160):210011. https:\/\/doi.org\/10.1183\/16000617.0011-2021","journal-title":"Eur Respir Rev"},{"issue":"9","key":"5565_CR25","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s10067-023-06623-7","volume":"42","author":"EL Matteson","year":"2023","unstructured":"Matteson EL, Aringer M, Burmester GR, Mueller H, Moros L, Kolb M (2023) Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial. Clin Rheumatol 42(9):2311\u20132319. https:\/\/doi.org\/10.1007\/s10067-023-06623-7","journal-title":"Clin Rheumatol"},{"issue":"6","key":"5565_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.chest.2017.05.015","volume":"152","author":"TJ Doyle","year":"2017","unstructured":"Doyle TJ, Dellaripa PF (2017) Lung manifestations in the rheumatic diseases. Chest 152(6):1283\u20131295. https:\/\/doi.org\/10.1016\/j.chest.2017.05.015","journal-title":"Chest"},{"key":"5565_CR27","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3389\/fimmu.2019.01327","volume":"10","author":"S Gupta","year":"2019","unstructured":"Gupta S, Ferrada MA, Hasni SA (2019) Pulmonary manifestations of primary sj\u00f6gren\u2019s syndrome: underlying immunological mechanisms, clinical presentation, and management. Front Immunol 10:1327. https:\/\/doi.org\/10.3389\/fimmu.2019.01327","journal-title":"Front Immunol"},{"issue":"2","key":"5565_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0039-1688448","volume":"40","author":"A Chung","year":"2019","unstructured":"Chung A, Wilgus ML, Fishbein G, Lynch JP 3rd (2019) Pulmonary and Bronchiolar Involvement in Sjogren\u2019s syndrome. Semin Respir Crit Care 40(2):235\u2013254. https:\/\/doi.org\/10.1055\/s-0039-1688448","journal-title":"Semin Respir Crit Care"},{"issue":"140","key":"5565_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1183\/16000617.0011-2016","volume":"25","author":"T Flament","year":"2016","unstructured":"Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S (2016) Pulmonary manifestations of Sj\u00f6gren\u2019s syndrome. Eur Respir Rev 25(140):110\u2013123. https:\/\/doi.org\/10.1183\/16000617.0011-2016","journal-title":"Eur Respir Rev"},{"issue":"1","key":"5565_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/1744666X.2018.1411190","volume":"14","author":"F Atzeni","year":"2018","unstructured":"Atzeni F, Gerardi MC, Barilaro G, Masala IF, Benucci M, Sarzi-Puttini P (2018) Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review. Expert Rev Clin Immunol 14(1):69\u201382. https:\/\/doi.org\/10.1080\/1744666X.2018.1411190","journal-title":"Expert Rev Clin Immunol"},{"issue":"7","key":"5565_CR31","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.3390\/jcm12072586","volume":"12","author":"O Berardicurti","year":"2023","unstructured":"Berardicurti O, Marino A, Genovali I, Navarini L, D\u2019Andrea S, Currado D et al (2023) Interstitial lung disease and pulmonary damage in primary sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. J Clin Med 12(7):2586. https:\/\/doi.org\/10.3390\/jcm12072586","journal-title":"J Clin Med"},{"issue":"8","key":"5565_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/1756-185X.13881","volume":"23","author":"C He","year":"2020","unstructured":"He C, Chen Z, Liu S, Chen H, Zhang F (2020) Prevalence and risk factors of interstitial lung disease in patients with primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Int J Rheum Dis 23(8):1009\u20131018. https:\/\/doi.org\/10.1111\/1756-185X.13881","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"5565_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s40001-022-00828-3","volume":"27","author":"L Weng","year":"2022","unstructured":"Weng L, Chen Y, Liang T, Lin Y, Liu D, Yu C et al (2022) Biomarkers of interstitial lung disease associated with primary Sj\u00f6gren\u2019s syndrome. Eur J Med Res 27(1):199. https:\/\/doi.org\/10.1186\/s40001-022-00828-3","journal-title":"Eur J Med Res"},{"issue":"2","key":"5565_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102447","volume":"19","author":"G Sambataro","year":"2020","unstructured":"Sambataro G, Ferro F, Orlandi M, a, (2020) Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sj\u04e7gren\u2019s syndrome: a systematic review from the Italian Society of Rheumatology. Autoimmun Rev 19(2):102447. https:\/\/doi.org\/10.1016\/j.autrev.2019.102447","journal-title":"Autoimmun Rev"},{"issue":"4","key":"5565_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/17843286.2018.1521904","volume":"74","author":"N Berghen","year":"2019","unstructured":"Berghen N, Vulsteke JB, Westhovens R, Lenaerts J, De Langhe E (2019) Rituximab in systemic autoimmune rheumatic diseases: indications and practical use. Acta Clin Belg 74(4):272\u2013279. https:\/\/doi.org\/10.1080\/17843286.2018.1521904","journal-title":"Acta Clin Belg"},{"issue":"14","key":"5565_CR36","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1007\/s00018-021-03874-y","volume":"78","author":"H Mattoo","year":"2021","unstructured":"Mattoo H, Pillai S (2021) Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions. Cell Mol Life Sci 78(14):5527\u20135542. https:\/\/doi.org\/10.1007\/s00018-021-03874-y","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"5565_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cei.13238","volume":"195","author":"M Brown","year":"2019","unstructured":"Brown M, O\u2019Reilly S (2019) The immunopathogenesis of fibrosis in systemic sclerosis. Clin Exp Immunol 195(3):310\u2013321. https:\/\/doi.org\/10.1111\/cei.13238","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"5565_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13075-021-02586-9","volume":"23","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen S, Zheng S, Lin J, Hu S, Zhuang J et al (2021) The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases. Arthritis Res Ther 23(1):212. https:\/\/doi.org\/10.1186\/s13075-021-02586-9","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"5565_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/1573397116666201113091655","volume":"17","author":"SO da Silva","year":"2021","unstructured":"da Silva SO, da Paz AS, Farias IMVC, Moreira DS, Ribeiro MAF, Alves TSGN et al (2021) bronchoalveolar lavage in systemic sclerosis patients: a systematic review. Curr Rheumatol Rev 17(2):176\u2013183. https:\/\/doi.org\/10.2174\/1573397116666201113091655","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"5565_CR40","doi-asserted-by":"publisher","first-page":"19253","DOI":"10.1038\/s41598-022-23180-2","volume":"12","author":"JW Ha","year":"2022","unstructured":"Ha JW, Hong YJ, Cha HJ, Moon JD, Pyo JY, Lee SW et al (2022) A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis. Sci Rep 12(1):19253. https:\/\/doi.org\/10.1038\/s41598-022-23180-2","journal-title":"Sci Rep"},{"issue":"2","key":"5565_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jbspin.2017.11.006","volume":"85","author":"G Laustriat","year":"2018","unstructured":"Laustriat G, Ruyssen-Witrand A, Constantin A, Barnetche T, Adoue D, Cantagrel A et al (2018) Anti-citrullinated peptides antibodies in systemic sclerosis: Meta-analysis of frequency and meaning. Joint Bone Spine 85(2):147\u2013153. https:\/\/doi.org\/10.1016\/j.jbspin.2017.11.006","journal-title":"Joint Bone Spine"},{"issue":"3","key":"5565_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.semarthrit.2020.01.006","volume":"50","author":"M Elhai","year":"2020","unstructured":"Elhai M, Avouac J, Allanore Y (2020) Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: where do we stand? Semin Arthritis Rheum 50(3):480\u2013491. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.01.006","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"5565_CR43","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1111\/1756-185X.14206","volume":"24","author":"M Qiu","year":"2021","unstructured":"Qiu M, Nian X, Pang L, Yu P, Zou S (2021) Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: a systematic review and meta-analysis. Int J Rheum Dis 24(12):1449\u20131459. https:\/\/doi.org\/10.1111\/1756-185X.14206","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"5565_CR44","doi-asserted-by":"publisher","first-page":"21912","DOI":"10.1038\/s41598-020-78951-6","volume":"10","author":"C Meier","year":"2020","unstructured":"Meier C, Freiburghaus K, Bovet C et al (2020) Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease. Sci Rep 10(1):21912. https:\/\/doi.org\/10.1038\/s41598-020-78951-6","journal-title":"Sci Rep"},{"issue":"6","key":"5565_CR45","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1097\/MS9.0000000000000740","volume":"85","author":"S Adhikari","year":"2023","unstructured":"Adhikari S, Poudel P, Pathak S (2023) Systemic sclerosis with interstitial lung disease and myocardial infarction: a case report. Ann Med Surg 85(6):3043\u20133046. https:\/\/doi.org\/10.1097\/MS9.0000000000000740","journal-title":"Ann Med Surg"},{"issue":"1","key":"5565_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12931-019-0980-7","volume":"20","author":"V Cottin","year":"2019","unstructured":"Cottin V, Brown KK (2019) Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res 20(1):13. https:\/\/doi.org\/10.1186\/s12931-019-0980-7","journal-title":"Respir Res"},{"issue":"8","key":"5565_CR47","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3390\/jcm9082560","volume":"9","author":"GL Erre","year":"2020","unstructured":"Erre GL, Sebastiani M, Fenu MA, Zinellu A, Floris A, Cavagna L et al (2020) Efficacy, safety, and tolerability of treatments for systemic sclerosis-related interstitial lung disease: a systematic review and network meta-analysis. J Clin Med 9(8):2560. https:\/\/doi.org\/10.3390\/jcm9082560","journal-title":"J Clin Med"},{"issue":"26","key":"5565_CR48","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD et al (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380(26):2518\u20132528. https:\/\/doi.org\/10.1056\/NEJMoa1903076","journal-title":"N Engl J Med"},{"issue":"1","key":"5565_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/annrheumdis-2018-213708","volume":"78","author":"ER Volkmann","year":"2019","unstructured":"Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L et al (2019) Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Ann Rheum Dis 78(1):122\u2013130. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213708","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5565_CR50","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/rheumatology\/keac535","volume":"62","author":"CP Denton","year":"2023","unstructured":"Denton CP, Goh NS, Humphries SM, Maher TM, Spiera R, Devaraj A et al (2023) Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial. Rheumatology 62(5):1870\u20131876. https:\/\/doi.org\/10.1093\/rheumatology\/keac535","journal-title":"Rheumatology"},{"issue":"1","key":"5565_CR51","doi-asserted-by":"publisher","first-page":"00235","DOI":"10.1183\/23120541.00235-2020","volume":"7","author":"AM Hoffmann-Vold","year":"2021","unstructured":"Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Distler O (2021) Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review. ERJ Open Res 7(1):00235\u201302020. https:\/\/doi.org\/10.1183\/23120541.00235-2020","journal-title":"ERJ Open Res"},{"issue":"5","key":"5565_CR52","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.rmed.2014.02.006","volume":"108","author":"K Vincze","year":"2014","unstructured":"Vincze K, Kovats Z, Cseh A, Pasti K, Kiss E, Polgar A et al (2014) Peripheral CD4+ cell prevalence and pleuropulmonary manifestations in systemic lupus erythematosus patients. Respir Med 108(5):766\u2013774. https:\/\/doi.org\/10.1016\/j.rmed.2014.02.006","journal-title":"Respir Med"},{"issue":"22","key":"5565_CR53","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.3390\/jcm11226714","volume":"11","author":"JI Shin","year":"2022","unstructured":"Shin JI, Lee KH, Park S, Yang JW, Kim HJ, Song K et al (2022) Systemic Lupus Erythematosus and lung involvement: a comprehensive review. J Clin Med 11(22):6714. https:\/\/doi.org\/10.3390\/jcm11226714","journal-title":"J Clin Med"},{"issue":"3","key":"5565_CR54","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1573397113666170704102444","volume":"13","author":"K Tselios","year":"2017","unstructured":"Tselios K, Urowitz MB (2017) Cardiovascular and pulmonary manifestations of systemic Lupus Erythematosus. Curr Rheumatol Rev 13(3):206\u2013218. https:\/\/doi.org\/10.2174\/1573397113666170704102444","journal-title":"Curr Rheumatol Rev"},{"issue":"2","key":"5565_CR55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.semarthrit.2018.01.010","volume":"48","author":"JL Medlin","year":"2018","unstructured":"Medlin JL, Hansen KE, McCoy SS, Bartels CM (2018) Pulmonary manifestations in late versus early systemic lupus erythematosus: a systematic review and meta-analysis. Semin Arthritis Rheum 48(2):198\u2013204. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.01.010","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"5565_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13075-021-02435-9","volume":"23","author":"M Jiang","year":"2021","unstructured":"Jiang M, Chen R, Zhao L, Zhang X (2021) Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis. Arthritis Res Ther 23(1):57. https:\/\/doi.org\/10.1186\/s13075-021-02435-9","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5565_CR57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12016-019-08763-8","volume":"59","author":"T Xu","year":"2020","unstructured":"Xu T, Zhang G, Lin H, Xie Y, Feng Y, Zhang X et al (2020) Clinical characteristics and risk factors of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis based on observational studies. Clin Rev Allergy Immunol 59(3):295\u2013303. https:\/\/doi.org\/10.1007\/s12016-019-08763-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"5565_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.610257","volume":"7","author":"R Amarnani","year":"2021","unstructured":"Amarnani R, Yeoh SA, Denneny EK, Wincup C (2021) Lupus and the lungs: the assessment and management of pulmonary manifestations of systemic Lupus Erythematosus. Front Med 7:610257. https:\/\/doi.org\/10.3389\/fmed.2020.610257","journal-title":"Front Med"},{"issue":"11","key":"5565_CR59","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1177\/09612033231202398","volume":"32","author":"Y Liu","year":"2023","unstructured":"Liu Y, Cheng Z, Zha B, Chen X, Gong Z, Ji L et al (2023) Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: a meta-analysis. Lupus 32(11):1310\u20131319. https:\/\/doi.org\/10.1177\/09612033231202398","journal-title":"Lupus"},{"issue":"2","key":"5565_CR60","doi-asserted-by":"publisher","first-page":"2000337","DOI":"10.1183\/13993003.00337-2020","volume":"57","author":"PA Juge","year":"2021","unstructured":"Juge PA, Lee JS, Lau J, Kawano-Dourado L, Rojas Serrano J, Sebastiani M et al (2021) Methotrexate and rheumatoid arthritis associated interstitial lung disease. Eur Respir J 57(2):2000337. https:\/\/doi.org\/10.1183\/13993003.00337-2020","journal-title":"Eur Respir J"},{"issue":"12","key":"5565_CR61","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2169\/internalmedicine.2226-18","volume":"58","author":"I Kurata","year":"2019","unstructured":"Kurata I, Tsuboi H, Terasaki M, Shimizu M, Toko H, Honda F et al (2019) Effect of biological disease-modifying anti-rheumatic drugs on airway and interstitial lung disease in patients with rheumatoid arthritis. Intern Med 58(12):1703\u20131712. https:\/\/doi.org\/10.2169\/internalmedicine.2226-18","journal-title":"Intern Med"},{"issue":"3","key":"5565_CR62","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/14712598.2017.1287169","volume":"17","author":"J Chen","year":"2017","unstructured":"Chen J, Chi S, Li F, Yang J, Cho WC, Liu X (2017) Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies. Expert Opin Biol Ther 17(3):265\u2013283. https:\/\/doi.org\/10.1080\/14712598.2017.1287169","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"5565_CR63","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12890-023-02532-2","volume":"23","author":"M Xie","year":"2023","unstructured":"Xie M, Zhu C, Ye Y (2023) Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. BMC Pulm Med 23(1):255. https:\/\/doi.org\/10.1186\/s12890-023-02532-2","journal-title":"BMC Pulm Med"},{"key":"5565_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152031","volume":"55","author":"J Xu","year":"2022","unstructured":"Xu J, Xiao L, Zhu J, Qin Q, Fang Y, Zhang JA (2022) Methotrexate use reduces mortality risk in rheumatoid arthritis: a systematic review and meta-analysis of cohort studies. Semin Arthritis Rheum 55:152031. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152031","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"5565_CR65","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1007\/s10067-021-05691-x","volume":"40","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2021) COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 40(7):2611\u20132619. https:\/\/doi.org\/10.1007\/s10067-021-05691-x","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5565_CR66","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00296-023-05319-0","volume":"43","author":"Y Fedorchenko","year":"2023","unstructured":"Fedorchenko Y, Zimba O (2023) Long COVID in autoimmune rheumatic diseases. Rheumatol Int 43(7):1197\u20131207. https:\/\/doi.org\/10.1007\/s00296-023-05319-0","journal-title":"Rheumatol Int"},{"issue":"4","key":"5565_CR67","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00296-023-05529-6","volume":"44","author":"Y Fedorchenko","year":"2024","unstructured":"Fedorchenko Y, Mahmudov K, Abenov Z, Zimba O, Yessirkepov M (2024) Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs. Rheumatol Int 44(4):583\u2013591. https:\/\/doi.org\/10.1007\/s00296-023-05529-6","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05565-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T13:06:05Z","timestamp":1718370365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05565-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["5565"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05565-w","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"21 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}]}}